Shareholding disclosure

Christopher Brown

Declared position

54.8%

Threshold

Crossed upwards

Timeline

Published

19.11.2020

Transaction

12.11.2020

Transfer date

17.11.2020

Voting rights breakdown

Voting rights acquired54.8%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAKBI00088

Beneficial owner

Christopher Brown

Declared address

Christopher Brown, New York

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Christopher Brown

MindMaze Therapeutics Holding SA19.11.2020TAKBI00088

Disclosure summary

Christopher Brown disclosed a holding in MindMaze Therapeutics Holding SA on the acquisition side, published by SIX Exchange Regulation on 19.11.2020, at 54.8% of voting rights. Notice category: Single shareholder.

Disclosed position

54.8%

Voting rights acquired

Voting rights acquired54.8%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Christopher Brown disclosed a holding in MindMaze Therapeutics Holding SA, published on 19.11.2020.

Publication date19.11.2020

Transaction date12.11.2020

Transfer date17.11.2020

Issuing companyMindMaze Therapeutics Holding SA

Beneficial ownerChristopher Brown

Declared addressChristopher Brown, New York

CategorySingle shareholder

Voting rights acquired54.8%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAKBI00088

Source: SIX Exchange Regulation · Publication date: 19.11.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open